AI to help pathologists read stomach tissue samples
This trial tests whether an AI tool helps pathologists read your tissue samples more accurately. It's a study for people who have had a stomach biopsy or gastric cancer surgery, where digital images of the tissue are available.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a stomach biopsy or surgery to remove stomach cancer.
- Your doctors have digital images of your tissue sample and your medical information.
- Your tissue sample and medical records are complete and good enough for analysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how well artificial intelligence (AI) helps pathologists make diagnoses from digital tissue images. It may lead to faster and more accurate results for patients like you.
This trial uses artificial intelligence to analyze your pathology slides, radiology images, and medical records together. It aims to see how well AI can help with diagnosis or treatment planning, and you may qualify if your medical data is available and of good quality.
This trial tests an artificial intelligence model that helps doctors interpret a specific protein test (CLDN18.2) in stomach cancer tissue samples. It may help guide future treatment decisions.
This trial tests a computer-aided system used during upper endoscopy to find stomach growths that might be missed. It may help improve detection of early stomach cancer or precancerous changes.
This study tests whether an AI-assisted tool helps radiologists (doctors who read imaging scans) better interpret CT scans of gastric cancer patients. The research compares how accurately doctors read scans with and without AI help.
This study tests whether an AI tool can predict how well stomach cancer responds to chemotherapy before surgery. It uses CT scans and biopsy images taken before treatment starts to see if the AI can help guide future care.
Hear when a new Pathology Foundation Model trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.